Evidence map›Paper›PMID 39515756›Full record

Trial reportThe Journal of nutrition2025

Postprandial Effects of Four Test Meals Containing Wholegrain Rye or Refined Wheat Foods on Circulating Incretins, Ghrelin, Glucose, and Inflammatory Markers.

Sebastian Åberg, Dominic-Luc Webb, Elise Nordin, Per M Hellström, Rikard Landberg

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05004584 (Evaluation of Appetite Measure Visual Analogue Scales in Home-setting), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05004584 nacompletednot on this map

Evaluation of Appetite Measure Visual Analogue Scales in Home-setting: VASA-home

TypeinterventionalSponsorChalmers University of TechnologyRan2021 to 2021Enrolled29ConditionsOverweight and Obesity, Appetitive BehaviorArmsWheat home-based appetite assessment, Rye home-based appetite assessment, Wheat clinic-based appetite assessment, Rye clinic-based appetite assessment, Rye/Wheat clinic-based appetite assessment with blood sampling
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sebastian ÅbergDepartment of Life Sciences, Division of Food and Nutrition Science, Chalmers University of Technology, Gothenburg, Sweden. Electronic address: abergse@chalmers.se.
Dominic-Luc WebbDepartment of Medical Sciences, Gastroenterology and Hepatology, Uppsala University, Uppsala, Sweden.
Elise NordinDepartment of Life Sciences, Division of Food and Nutrition Science, Chalmers University of Technology, Gothenburg, Sweden.
Per M HellströmDepartment of Medical Sciences, Gastroenterology and Hepatology, Uppsala University, Uppsala, Sweden.
Rikard LandbergDepartment of Life Sciences, Division of Food and Nutrition Science, Chalmers University of Technology, Gothenburg, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh intake of whole grains has consistently been associated with reduced risk of obesity, coronary artery disease, and type 2 diabetes. Dietary interventions have shown beneficial metabolic effects of whole grains, but the metabolic response varies with different types of cereals.

objectivesWe evaluate the metabolic effects of substituting refined wheat with wholegrain rye foods within a complex diet, examining the day-long postprandial response of glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1), ghrelin, glucose, and inflammatory biomarkers in individuals with overweight and obesity.

methodsTwenty-nine healthy adults with body mass index of 32 ± 9 kg/m

resultsNo differences in GIP, GLP-1, or ghrelin levels were found between the diets when measured throughout the whole intervention day. GIP total area under the curve after the rye-based lunch was 31% (P < 0.05) lower compared with the wheat-based lunch, and ghrelin concentrations were 29% (P < 0.05) lower after the rye-based dinner. Baseline Homeostatic Model Assessment for Insulin Resistance-adjusted model showed 61% (P = 0.015) lower whole-day GLP-1 and 40% (P = 0.03) lower GIP after the rye-based diet. Day-long glucose incremental area under the curve was 30% (P < 0.001) lower after the rye-based diet, and glycemic variability was measured as SD reduced (-0.13 mmol/L, P = 0.04). The rye-based diet compared with refined wheat induced higher glycoprotein N-acetylation A, as measured by z-scores (0.36, P = 0.014).

conclusionsOverall, no day-long differences in gut hormone levels were observed, but the wholegrain rye-based compared with refined wheat-based dinner showed lower postprandial ghrelin concentrations. The rye-based diet improved day-long glycemic control in individuals with overweight and obesity. Observations of diet-induced inflammation after whole-grain rye intake warrant further investigation. TRIAL REGISTRATION NUMBER: This study was registered at Clinical Trials Registry of clinicaltrials.gov (NCT05004584): https://clinicaltrials.gov/study/NCT05004584?locStr=Gothenburg,%20Sweden&country=Sweden&state=V%C3%A4stra%20G%C3%B6taland%20County&city=Gothenburg&distance=50&term=appetite&aggFilters=status:com&rank=1.

Indexed as

Blood GlucoseGhrelinIncretinsPostprandial PeriodSecaleTriticumWhole GrainsAdultBiomarkersFemaleGastric Inhibitory PolypeptideGlucagon-Like Peptide 1HumansInflammationMaleMealsBiomarkersBlood GlucoseGastric Inhibitory PolypeptideGhrelinGlucagon-Like Peptide 1Incretinsappetite regulationclinical trialcontinuous glucoseghrelinincretinobesityoverweightpostprandial glucosepostprandial incretinwholegrain rye

Identifiers

PMID39515756
PMCPMC11795698

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.